首页> Biomaterials> Nanoquadruplex-driven hydrogen therapy: NIR-controlled release for targeted cancer ferroptosis.

Nanoquadruplex-driven hydrogen therapy: NIR-controlled release for targeted cancer ferroptosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Chunxue,Dai

第一单位： School of Life Sciences, Anhui Agricultural University, Hefei, Anhui, 230036, China.

作者： Chunxue,Dai ^[1] ; Yingjiao,He ^[1] ; Hongyan,Lu ^[1] ; Xiaotong,Feng ^[2] ; Naling,Long ^[1] ; Qile,Song ^[2] ; Yuwei,Li ^[1] ; Yifan,Wang ^[2] ; Lisandra L,Martin ^[3] ; Cundong,Fan ^[4] ; Dongdong,Sun ^[5]

作者单位： School of Life Sciences, Anhui Agricultural University, Hefei, Anhui, 230036, China. ^[1] Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, 271000, Shandong, China. ^[2] School of Chemistry, Monash University, Clayton, 3800, Victoria, Australia. Electronic address: Lisa.Martin@monash.edu. ^[3] Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, 271000, Shandong, China. Electronic address: cdfan@sdfmu.edu.cn. ^[4] School of Life Sciences, Anhui Agricultural University, Hefei, Anhui, 230036, China. Electronic address: sunddwj@ahau.edu.cn. ^[5]

关键词 Cancer ferroptosis Hydrogen therapy Nanoquadruplex (PdH(0.2))(4)Se Near-infrared (NIR) activation Reactive oxygen species (ROS)